Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INSR | P06213 | 2/20 | 0.53 |
| ▸ | RELA | Q04206 | 2/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.50 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.49 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | KDM4A | O75164 | 4/20 | 0.45 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.45 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5712602 | 1.00 | INSR (0.53) | INSRRELACHRM2CHRM4CHRM5 | |
| SCHEMBL28387158 | 0.98 | INSR (0.55) | INSRRELACHRM2CHRM4CHRM5 | |
| SCHEMBL9822952 | 0.98 | INSR (0.55) | INSRRELACHRM2CHRM4CHRM5 | |
| SCHEMBL13091028 | 0.95 | CHRM2 (0.55) | INSRRELACHRM2CHRM4CHRM5 | |
| SCHEMBL5712573 | 0.93 | CHRM2 (0.55) | INSRCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL5712574 | 0.93 | CHRM2 (0.55) | INSRCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL1832514 | 0.93 | CHRM2 (0.55) | INSRCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL2604957 | 0.91 | CHRM2 (0.57) | INSRCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL7719119 | 0.91 | CHRM2 (0.54) | INSRCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL1832513 | 0.90 | INSR (0.51) | INSRCHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7276627-B2 | One pot sequential reactions and novel products produced thereby | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2007-10-02 | — | — | US | claimed |
| US-20060224017-A1 | One pot sequential reactions and novel products produced thereby | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2006-10-05 | — | — | US | claimed |
| US-20120299045-A1 | ORGANIC ELECTROLUMINESCENT DEVICE WITH INTEGRATED LAYER FOR COLOUR CONVERSION | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2012-11-29 | — | — | US | disclosed |
| US-7276627-B2 | One pot sequential reactions and novel products produced thereby | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2007-10-02 | — | — | US | disclosed |
| US-20060224017-A1 | One pot sequential reactions and novel products produced thereby | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2006-10-05 | — | — | US | disclosed |
| US-20060214553-A1 | Organic electroluminescent device | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2006-09-28 | — | — | US | disclosed |
| US-20060158104-A1 | Organic EL device | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2006-07-20 | — | — | US | disclosed |
| EP-1670083-A2 | Organic el device | Kabushiki Kaisha Toyota Jidoshokki (JP) | 2006-06-14 | — | — | EP | disclosed |
| EP-1613132-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Kabushiki Kaisha Toyota Jidoshokki (JP) | 2006-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060224017-A1 | One pot sequential reactions and novel products produced thereby | PNMT, CYP1A1, TERT | INSR 848/4885RELA 1503/4885CHRM2 4567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.